Lexology October 3, 2023
Duane Morris LLP

The FDA recently released three draft guidance documents that aim to “modernize” the 510(k) premarket notification process. This process permits medical device manufacturers to market a new device in the United States provided that they can show it is “substantially equivalent” to a device that has already been cleared by the FDA (i.e., a “predicate device”). The 510(k) clearance pathway is used for the vast majority of devices that the FDA reviews as it recognizes a balance between promoting innovation and patient safety. Starting in 2018, the agency began to express an intent to modernize the pathway while still ensuring a proper balance of the dual aims of innovation and patient safety.

In issuing these new draft guidance documents, the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies, Medical Devices
Who’s Leading the FDA’s AI Race? Top Medical Specialties and Companies to Watch
FDA issues flu vaccine recommendations: 5 respiratory updates
5 Digital Health Areas To Be Impacted By The FDA Layoffs
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee

Share This Article